Aortic & peripheral vascular diseaseCohort study

Contemporary Practice Patterns and Outcomes of Endovascular Revascularization of Acute Limb Ischemia

JACC Cardiovasc IntervPublished

  • Retrospective registry study
  • nationwide
  • multicenter

Authors' conclusion

Patients with pre-existing medical comorbidities and those with diminished limb viability were more likely to suffer adverse outcomes. Adverse event rates remain high for patients affected by acute limb ischemia despite its declining incidence.

Study context

Population
Patients undergoing peripheral vascular intervention for acute limb ischemia, NCDR PVI Registry, 2014–2020
Participants
3,541 endovascular procedures
Outcome
Composite of:
  • All-cause mortality
  • Major amputation
Follow-up
During index hospitalization

Main finding

As reported in the abstract

Death and amputation during hospitalization · index hospitalization

Death

132 (3.7%)

Amputation

77 (2.2%)

Observational data: associations, not effects.

Further findings

Independent predictors of death or amputation (multivariable logistic regression)

ComparisonOR (95% CI)
Severe lung disease1.72 (1.17–2.52)
Rutherford Class IIb2.44 (1.62–3.65)
Preprocedure hemoglobin0.78 (0.73–0.85)
OutcomeOR (95% CI)
Independent predictors of death or amputation (multivariable logistic regression) — End-stage renal disease · CI as printed3.94 (0.73–0.85)

Device use

Thrombolysis catheters
27.7% (n = 981)
Thrombectomy catheters
3.9% (n = 138)

Safety

Complications

Bleeding within 72 hours of intervention
6.7%
Thrombosis
2.8%

Original publication

Contemporary Practice Patterns and Outcomes of Endovascular Revascularization of Acute Limb Ischemia. JACC Cardiovasc Interv. Published 28 October 2024. doi:10.1016/j.jcin.2024.09.010

Summarised from the published abstract; every number is checked against it